Trial Profile
A phase III study of KD-332 multicenter, randomized, double-blind, parallel-group, comparative study of healthy children using DTaP vaccine and live-oral Polio vaccine as comparator vaccines.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs DTaP poliovirus vaccine (Primary) ; DTaP vaccine; Poliovirus vaccine live oral
- Indications Diphtheria; Pertussis; Poliomyelitis; Tetanus
- Focus Pharmacodynamics
- 03 Jun 2016 New trial record